{"product_id":"b-pruthvishree-s-epidemiology-of-carbapenem-resistant-escherichia-coli-from-piglets-9786209180675","title":"Epidemiology of carbapenem resistant Escherichia coli from piglets","description":"To study the epidemiology of carbapenem resistant E. coli isolates from piglet faecal samples a cross section study was conducted in 10 different locations and total of 673 faecal swabs were collected. On preliminary screening with 1 mg\/L imipenem added MacConkey ag 112 E. coli isolates were isolated. The phenotypic screening of 112 isolates with carbapenem antibiotics, aztreonam and moxalactam showed resistance of 18.80 % for meropenem, 9.80% for imipenem, 16.1 % ertapenem, 14.30 % aztreonam and 9.80% for moxalactam. Out of 112 E. coli isolates, 79 (70.54 %) had meropenem MIC between 1 ¿g and 2 ¿g \/mL (sensitive) and 10 (8.92%) had MIC between 2 and 4 ¿g\/mL (intermediate) and 23 isolates (20.54 %) had meropenem MIC more than 4 ¿g\/mL (resistant). Twenty three isolates were carbapenem resistant, out of which 8 isolates showed keyhole reaction with EDTA and on genotypic screening all were NDM positives. The efflux pump screening of 15 carbapenemase genes negative isolates, 8 isolates showed efflux pump mediated resistance. The remaining 7 isolates showed neither carbapenemase gene nor efflux pump mediated resistance.","brand":"LAP LAMBERT Academic Publishing","offers":[{"title":"Default Title","offer_id":53769199878486,"sku":null,"price":0.0,"currency_code":"EUR","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0925\/5829\/5382\/files\/product_image_9786209180675_1.jpg?v=1781804769","url":"https:\/\/www.momoxbooks.com\/products\/b-pruthvishree-s-epidemiology-of-carbapenem-resistant-escherichia-coli-from-piglets-9786209180675","provider":"momoxbooks","version":"1.0","type":"link"}